![]() |
市場調査レポート
商品コード
1781174
ノミ・ダニ駆除製品の世界市場、製品タイプ別、ペットの種類別、寄生虫別、流通チャネル別、地域別、機会、予測、2018年~2032年Global Flea and Tick Product Market Assessment, By Product Type, By Pet Type, By Parasite, By Distribution Channel, By Region, Opportunities, and Forecast, 2018-2032F |
||||||
カスタマイズ可能
|
ノミ・ダニ駆除製品の世界市場、製品タイプ別、ペットの種類別、寄生虫別、流通チャネル別、地域別、機会、予測、2018年~2032年 |
出版日: 2025年08月01日
発行: Markets & Data
ページ情報: 英文 228 Pages
納期: 3~5営業日
|
世界のノミ・ダニ駆除製品市場は、ペット飼育の増加、人畜共通感染症に対する意識の高まり、害虫駆除ソリューションの進歩などが相まって、2025~2032年の予測期間中にCAGR 7.56%を記録し、2024年の80億4,000万米ドルから2032年には144億米ドルに成長すると予測されています。促進要因のひとつは、ペット飼育の増加とペットの人間化です。多くの人々がペットを飼い、家族として扱うようになり、ペットの健康への支出増加に寄与しています。ライム病やエーリキア症など、ノミやマダニが媒介する病気に対する意識が高まり、ペットの飼い主が予防治療を求めるようになり、獣医師は季節的な使用ではなく、通年の予防を処方するようになりました。気温の上昇によって寄生虫の生息域と活動時期が拡大し、ペットが寄生虫にさらされるリスクが高まるという気候変動も、この市場を牽引しています。
製品革新が市場成長の主な原動力となっており、投与が容易な経口錠剤、長持ちする首輪、天然代替品などの革新的製品が圧倒的なシェアを占めています。eコマースとペットケア小売の成長により、これらの製品はこれまで以上に入手しやすくなり、定期購入モデルは定期的な使用を促しています。特に新興国市場における可処分所得の増加も需要を支えており、ペットヘルスケアへの支出の増加やペット保険の普及も後押ししています。医師の勧めは重要な役割を果たし、そうした専門家は処方箋グレードの薬を勧め、新しい有効成分の規制クリアランスは消費者の信頼を高めています。さらに、ロッキー山斑点熱など、ノミやダニが媒介する人獣共通感染症への懸念も、予防ソリューションへの需要を支えています。将来的には、AIを利用した害虫の追跡、カスタマイズされたペットヘルスケアソリューション、アジア太平洋とラテンアメリカの市場成長などの新技術が、業界の成長をさらに促進すると思われます。
例えば、2023年8月、ベーリンガーインゲルハイム・インターナショナルGmbHは、インドにおけるネクスガード(アフォキソラナー)SおよびM市場の拡大を発表しました。この拡大は、NexGard XおよびLの発売後に行われ、小型犬(2~4kg)および中型犬(4~10kg)向けのNexGard製品ラインを拡大するものです。
上記の企業は市場シェアに応じて注文を保留するものではなく、調査作業中に入手可能な情報に応じて変更される可能性があります。
Global flea and tick product market is projected to witness a CAGR of 7.56% during the forecast period 2025-2032, growing from USD 8.04 billion in 2024 to USD 14.40 billion in 2032, owing to a combination of increasing pet ownership, rising awareness of zoonotic diseases, and advancements in pest control solutions. Among the drivers is increased pet ownership and humanization of pets, as more people own pets and treat them as family, contributing to increased expenditure on pet health. Increased sensitization about flea and tick-borne diseases, including Lyme disease and ehrlichiosis, has also led to pet owners demanding preventive treatment, with veterinarians prescribing year-round protection rather than seasonal use. Climate change is another driver, with warmer temperatures increasing the range and activity seasons of parasites, raising exposure risks for pets.
Product innovation has been a primary market growth driver, with innovations such as easy-to-administer oral pills, long-lasting collars, and natural alternatives commanding a dominant share. Growth of e-commerce and pet care retail has made these products more accessible than ever, while subscription models encourage regular usage. Rising disposable income, particularly in developing markets, has also supported demand, aided by rising expenditure on pet healthcare and growing acceptance of pet insurance. Doctor recommendations play an important role, with such experts recommending prescription-grade medication, while regulatory clearances of new active ingredients enhance consumer confidence. Furthermore, fears of zoonotic diseases spread by fleas and ticks, such as Rocky Mountain spotted fever, have also supported demand for preventive solutions. In the future, new technologies such as AI-based tracking of pests, customized pet healthcare solutions, and market growth in Asia-Pacific and Latin America are likely to fuel the industry's growth even further.
For instance, in August 2023, Boehringer Ingelheim International GmbH announced its expansion of NexGard (afoxolaner) S and M markets in India. The expansion comes after the launch of NexGard X and L and expands the NexGard product line for small (2-4 kg) and medium (4-10 kg) dogs.
Rising Pet Ownership and Humanization of Pets Drives the Global Flea and Tick Product Market Demand
The growing trend of pet ownership and the humanization of pets are key drivers of the demand seen in the global flea and tick product market. As more families embrace pet adoption, especially in the post-COVID-19 era, companion animals are considered part of the family, with more financial investment in their health and wellness. The change in attitude has raised awareness of the importance of pet care, especially protection from fleas and ticks, which trigger distress and disease transmission. As pets are taking a more central position in the family, owners are increasingly turning to a proactive approach in preventive care, seeking veterinarian-approved treatments for fleas and ticks. With the pet humanization trend showing no signs of slowing, the flea and tick product market is poised to see steady growth, fueled by increasing pet care spending and intense focus on the health and safety of pets.
For instance, in May 2025, FurLife Canine Essentials LLC introduced two new products, the FurLife flea and tick shampoo for dogs and cats and FurLife flea and tick spray for dogs and cats. They are natural, plant-powered alternatives that provide effective chemical-free protection against fleas, ticks and ear mites for pets at any stage of life.
Growing Awareness of Flea and Tick-Borne Diseases Expands Global Flea and Tick Product Market Size
The increasing recognition of the health implications of flea- and tick-borne diseases is driving the growth of the global flea and tick product market. Healthcare practitioners and pet guardians are becoming more conscious of diseases like lyme disease, ehrlichiosis, and anaplasmosis that can affect humans and animals. This is additional knowledge, driven by veterinary advice and public health promotion, that has led to more comprehensive year-round prevention treatments, rather than seasonal application. The zoonotic potential of these parasites has generated increased demand, with consumers wanting to protect their pets and families from infection. Pharmaceutical development, in the form of advanced oral preventatives and long-acting topical treatments, is becoming more popular as pet owners increasingly prioritize efficacy and convenience. Education campaigns from market participants and animal welfare groups continue to highlight the need for ongoing parasite control and thus drive market expansion. As recognition of vector-borne diseases gathers momentum and preventive medicine becomes the norm, the flea and tick product market are set to grow faster, with manufacturers developing increasingly advanced solutions to meet changing consumer needs.
For instance, in July 2025, MSD Animal Health announced the United States FDA approval of Bravecto Quantum (fluralaner for extended-release injectable suspension) for dogs. This innovative injectable provides 12-month protection against most tick species and fleas (representing a significant step forward in convenience for pet owners.
Dog Segment Dominates the Global Flea and Tick Product Market
Global flea and tick product market is dominated largely by the dog segment, and it commands the largest share owing to several vital factors. One of the favorite companion animals in the world, dogs are more vulnerable to flea and tick infestations than other companion animals owing to their outdoor lifestyle and their closer exposure to environments where such parasites are most likely to flourish. The increased exposure has witnessed a high demand for prevention and treatment products specifically designed for the canines. Companies concentrate on products specifically designed for dogs, with a broad range of choices made available, such as spot-on products, oral chewable, medicated collars, and shampoos. The segment captures high compliance rates among pet owners, supported by veterinarian advice that promotes year-round parasite prevention. The pet humanization trend has also supported higher expenditure on the health of dogs, further driving market growth. With ongoing innovations in canine flea and tick control and rising dog ownership throughout the world, the segment is predicted to continue dominating, solidifying its position as the growth driver in the flea and tick product market.
For instance, in April 2025, MSD Animal Health (UK subsidiary) received marketing authorization from the Veterinary Medicines Directorate (VMD) for Bravecto TriUNO. This new monthly chewable formulation for dogs' targets both internal and external parasites, offering comprehensive protection in one convenient dose.
North America Region Leads the Global Flea and Tick Product Market
The North American market is recognized as the top leader in the global flea and tick product market with the largest market share. This leadership is a result of several key factors that together facilitate enormous market growth. The region initially has extremely high rates of pet ownership, particularly in the United States, where over half of household's own pets. This condition provides a significant customer base for flea and tick preventatives. Further, the highly advanced pet humanization culture in North America also drives demand further as pet owners increasingly seek high-end healthcare products for their pet animals. The market is also aided by advanced veterinary infrastructure as well as a shared awareness of zoonotic diseases that parasites can transfer. Routine trips to the veterinarian and preventive healthcare have become standard practice, with veterinarians actively recommending year-round flea and tick protection. Further, North America is an innovation center for products controlling fleas and ticks, with several leading industry players based there. As pet healthcare expenditure continues to increase and product development progresses, North America is well positioned to continue its leading role in the global flea and tick product market in the near term.
For instance, in May 2025, Central Garden & Pet Company launched ADAMS Botanicals Flea & Tick Pet & Home Spray. This new EPA-approved, plant-based spray for dogs, cats, pet bedding, and home surfaces marks the brand's 50th anniversary.
Impact of the U.S. Tariff on Global Flea and Tick Product Market
The imposition of U.S. tariffs on imported goods, including pet care products, has created significant ripple effects across the global flea and tick product market. As the largest consumer of these products, U.S. trade policies directly influence pricing, supply chains, and competitive dynamics worldwide.
Tariffs on raw materials (e.g., active pharmaceutical ingredients from China and India) and finished goods have raised manufacturing costs.
Companies may pass these costs to consumers, leading to higher retail prices for flea and tick treatments, particularly for budget-conscious pet owners.
Manufacturers reliant on imported ingredients face delays and increased logistical expenses.
Key Players Landscape and Outlook
The global flea and tick product market is characterized by intense competition among leading pharmaceutical companies, insurgent innovators, and private-label companies, each pursuing different strategies to capture market share. Industry leaders dominate with their market-leading brands, supported by high research and development spending and extensive veterinary networks. Brands continue to reassert themselves in the market with innovation in oral preventatives and strategic forays in emerging markets. In the near term, the market is likely to witness seismic change through the expected expirations of patents on market-leading brands, which is expected to precipitate the launch of generics and increase price competition. The trend towards combination products with multi-parasite protection is gaining traction, driven by consumer convenience preference and the manufacturers' desire to achieve higher profit margins. As the market continues to evolve, the dynamic between incumbent players and agile disruptors will shape the competitive landscape of the future, with innovation and strategic agility emerging as key determinants in this rapidly evolving landscape.
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.